Galmed Pharmaceuticals Takes the Leap into Crypto Payroll
In a bold and unexpected move, Galmed Pharmaceuticals has decided to allocate 50% of its cash reserves into digital assets. This could mean big things for the biopharma sector and how it handles finances in the future. The question now is how this affects regulatory frameworks and what it could mean for other companies.
Galmed’s Crypto Payroll Strategy Explained
On August 25, 2025, Galmed Pharmaceuticals, a clinical-stage biopharma firm from Tel Aviv, made a huge announcement: they’re investing up to $5 million into digital assets. They’re not messing around, either. Half of their $10 million cash reserves will be directed into cryptocurrencies. They’re partnering with Tectona Ltd., a crypto treasury management company, to make…
